The New England medical device startup community is an amazing innovation ecosystem, producing great products and great companies over several decades. New startups are the lifeblood of that ecosystem, so I’ve been tracking first-time venture financing of medical device companies in New England since 2005.
I’m way overdue for an update. You’ll find my 2014 Q4 New England Venture Funded Medical Device Startup List linked below.
Continue reading “New England Venture Funded Medical Device Startup List 2014 Q4”
Another year has gone by since I last updated my list of healthcare venture capital funds with money to invest. Better late than never, I guess.
Today, I’m happy to post an updated list, complete through November 2014. Good news: lots of new funds have been (or are being) raised!
Continue reading “List of Active Healthcare Venture Capital Investors – 2014 Q4”
In case you aren’t paying attention, novel medical devices are changing the world. Some recent clinical trial headlines:
Ardian’s Renal Denervation System Demonstrates Sustained Blood Pressure Reduction at 30 Month Follow Up
Asthmatx Bronchial Thermoplasty Provides Long Term Asthma Control Out to 5 Year Follow Up
Percutaneous Valve Technologies’ and CoreValve’s Real World Registry Data Show That Transcatheter Valves Dramatically Improve New York Heart Association class III/IV symptoms and Angina
Barrx’s Endoscopic Ablation Therapy Eliminates Precancerous Esophageal Tissue and Significantly Reduces Disease Progression In Patients with Low Grade Dysplasia
EndoGastric Solutions’ Incisionless Endoscopic Procedure Significantly More Effective at Eliminating Chronic GERD Symptoms than Maximum PPI Dose, New Data Show
CV Ingenuity’s drug-eluting balloon demonstrates good 12 month efficacy in peripheral arterial disease.
Making a real and lasting impact – that’s what medical device startups are all about.
That’s why I do what I do.
US healthcare system consolidation, and the increasing percentage of US employment of physicians directly by healthcare systems, are dramatically changing the US medical device market, as I’ve previously discussed here, here, and here.
This week, Evan Anderson presents a first-hand view of these changes in a great article on the Stanford Biodesign Alumni blog. Highly recommended.